A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Clinical trial NCT04729114 · RECRUITING

Trial details

NCT number: NCT04729114
Sponsor: Astellas Pharma Global Development, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration Resistant Prostate Cancer Metastatic Castration-sensitive Prostate Cancer

Start date: 2021-06-14
Primary completion: 2029-05-31
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.